Clearmind Medicine Inc. Common Shares (CMND) — Cash Flow-to-Debt Ratio
Clearmind Medicine Inc. Common Shares (CMND) has a Cash Flow-to-Debt Ratio of -0.72x as of January 2026, meaning its operating cash flow of $-2.08 Million could theoretically repay -1% of its total liabilities ($2.90 Million) in one year. Check CMND capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Clearmind Medicine Inc. Common Shares Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Clearmind Medicine Inc. Common Shares across 12 annual periods. Also explore CMND total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Clearmind Medicine Inc. Common Shares (2014–2025)
Year-by-year debt coverage analysis for Clearmind Medicine Inc. Common Shares. For market capitalisation and broader financial context, see CMND market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.97x | $-4.73 Million | $4.89 Million | ▲ +17.4% |
| 2024 | -1.17x | $-6.76 Million | $5.77 Million | ▲ +7.6% |
| 2023 | -1.27x | $-6.30 Million | $4.97 Million | ▲ +34.2% |
| 2022 | -1.93x | $-5.06 Million | $2.62 Million | ▲ +73.3% |
| 2021 | -7.21x | $-2.08 Million | $288.19K | ▲ +63.6% |
| 2020 | -19.79x | $-198.50K | $10.03K | ▼ -1299.9% |
| 2019 | -1.41x | $-47.85K | $33.85K | ▲ +89.8% |
| 2018 | -13.82x | $-80.48K | $5.83K | ▼ -7665.7% |
| 2017 | -0.18x | $-9.12K | $51.28K | ▲ +42.1% |
| 2016 | -0.31x | $-15.37K | $50.01K | ▲ +83.2% |
| 2015 | -1.83x | $-39.81K | $21.76K | ▼ -105.2% |
| 2014 | -0.89x | $-28.01K | $31.43K | — |